Joshua Kazam

Joshua Kazam

Net worth: 637 541 $ as of 2026-09-29

49 year
Finance
Health Technology
Consumer Non-Durables

Profile

Mr. Joshua A. Kazam is an Independent Director at Soaring Eagle Acquisition Corp., an Independent Director at Tishman Speyer Innovation Corp. II, an Independent Director at TS Innovation Acquisitions Corp., a Director & Partner at Vida Ventures LLC, a Partner at Two River Consulting LLC, a Director & Co-Owner at Riverbank Capital Securities, Inc., a Co-Founder & Partner at Two River Group Holdings LLC, a Co-Founder at VV Manager LLC, a Director & Vice President at Two River Group Management LLC, a Member-Executive Board at The Wharton School of the University of Pennsylvania and a Principal at BCIF Pty Ltd. He is on the Board of Directors at Soaring Eagle Acquisition Corp., Tishman Speyer Innovation Corp. II, TS Innovation Acquisitions Corp., Breakthrough Properties LLC, Breakthrough Services LLC, Allogene Therapeutics, Inc., Vida Ventures LLC, Kronos Bio, Inc., ByHeart, Inc., Desert Flower Foundation GmbH, Vision Path, Inc., MedPod, Inc., Veterinary Prime, Inc., Riverbank Capital Securities, Inc., 105 W First Street LLC, Cortiva Therapy, Danube Pharmaceuticals, Inc., Kirax Corp., Tranzutary Holdings LLC, Vetprime, Inc. and Two River Group Management LLC. Mr. Kazam was previously employed as an Independent Director by Flying Eagle Acquisition Corp., an Independent Director by Diamond Eagle Acquisition Corp., an Independent Director by Platinum Eagle Acquisition Corp., an Independent Director by Capricor Therapeutics, Inc., a Director-Investment Management by Orion Biomedical Fund LP, a Managing Director by Paramount BioCapital, Inc., and a Chief Executive Officer & Director by IconOVir Bio, Inc. He also served on the board at Kite Pharma, Inc., Velcera, Inc., Arno Therapeutics, Inc., Nile Therapeutics, Inc. /Old/, Arno Therapeutics, Inc. /Old/, Manhattan Pharmaceuticals, Inc. and Velcera Pharmaceuticals, Inc. /Old/. He received his undergraduate degree from The Wharton School of the University of Pennsylvania.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-06-17 398,463 ( 0.12% ) 637 541 $ 2026-09-29

Joshua Kazam active positions

CompaniesPositionStart
ALLOGENE THERAPEUTICS, INC. Founder 2017-10-31
Investment Committee Member -
Founder 2017-10-31
Director/Board Member 2019-03-31
Founder -
Founder 2016-10-31
Director/Board Member -
Director/Board Member -
Director/Board Member -
░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░

Former positions of Joshua Kazam

CompaniesPositionEnd
░░░░░░ ░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Joshua Kazam's experience

Education of Joshua Kazam

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

50

1st degree connections

44

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies44

Health Technology

Finance

Finance

Health Technology

Finance

Health Technology

Health Technology

Technology Services

Orion Biomedical Fund LP

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Cortiva Therapy

Health Technology

Health Technology

Consumer Services

Tranzutary Holdings LLC

Consumer Non-Durables

Vetprime, Inc.

Retail Trade

Desert Flower Foundation GmbH

Finance

Finance

Finance

Finance

Retail Trade

Health Technology

Health Technology

Consumer Non-Durables

Finance

Finance

Finance

Finance

Finance

Finance

Health Technology

Finance

Finance

Finance

Finance

Health Technology